Want to join the conversation?
$CELG's sales from Pomalyst/Imnovid for 3Q15 jumped by 41.6% from last year, reflecting net sales of $150.1MM in the U.S. and $106.4MM in international markets. Increases in market share and treatment duration contributed to the increase in U.S. and international net sales of Pomalyst/Imnovid.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.